Modest familial risks for multiple sclerosis: a registry-based study of the population of Sweden H Westerlind, R Ramanujam, D Uvehag, R Kuja-Halkola, M Boman, ... Brain 137 (3), 770-778, 2014 | 213 | 2014 |
Effect of smoking cessation on multiple sclerosis prognosis R Ramanujam, AK Hedström, A Manouchehrinia, L Alfredsson, T Olsson, ... JAMA neurology 72 (10), 1117-1123, 2015 | 202 | 2015 |
Importance of early treatment initiation in the clinical course of multiple sclerosis A Kavaliunas, A Manouchehrinia, L Stawiarz, R Ramanujam, J Agholme, ... Multiple Sclerosis Journal 23 (9), 1233-1240, 2017 | 175 | 2017 |
Age related multiple sclerosis severity score: disability ranked by age A Manouchehrinia, H Westerlind, E Kingwell, F Zhu, R Carruthers, ... Multiple Sclerosis Journal 23 (14), 1938-1946, 2017 | 136 | 2017 |
IgA deficiency and the MHC: assessment of relative risk and microheterogeneity within the HLA A1 B8, DR3 (8.1) haplotype J Mohammadi, R Ramanujam, S Jarefors, N Rezaei, A Aghamohammadi, ... Journal of clinical immunology 30, 138-143, 2010 | 78 | 2010 |
Changes to anti-JCV antibody levels in a Swedish national MS cohort C Warnke, R Ramanujam, T Plavina, T Bergström, S Goelz, ... Journal of Neurology, Neurosurgery & Psychiatry 84 (11), 1199-1205, 2013 | 76 | 2013 |
Multidimensional persistence and noise M Scolamiero, W Chachólski, A Lundman, R Ramanujam, S Öberg Foundations of Computational Mathematics 17, 1367-1406, 2017 | 71 | 2017 |
Utilizing twins concordance rates to infer the predisposition to myasthenia gravis R Ramanujam, R Pirskanen, S Ramanujam, L Hammarström Twin research and human genetics 14 (2), 129-136, 2011 | 65 | 2011 |
PTPN22 R620W promotes production of anti-AChR autoantibodies and IL-2 in myasthenia gravis AK Lefvert, Y Zhao, R Ramanujam, S Yu, R Pirskanen, L Hammarström Journal of neuroimmunology 197 (2), 110-113, 2008 | 59 | 2008 |
Association of pre-disease body mass index with multiple sclerosis prognosis A Manouchehrinia, AK Hedström, L Alfredsson, T Olsson, J Hillert, ... Frontiers in neurology 9, 317592, 2018 | 40 | 2018 |
Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: a descriptive study of test results J Link, R Ramanujam, M Auer, M Ryner, S Hässler, D Bachelet, ... PLoS One 12 (2), e0170395, 2017 | 37 | 2017 |
Occurrence of anti-drug antibodies against interferon-beta and natalizumab in multiple sclerosis: a collaborative cohort analysis D Bachelet, S Hässler, C Mbogning, J Link, M Ryner, R Ramanujam, ... PloS one 11 (11), e0162752, 2016 | 37 | 2016 |
Concomitant autoimmunity in myasthenia gravis—lack of association with IgA deficiency R Ramanujam, F Piehl, R Pirskanen, PK Gregersen, L Hammarström Journal of neuroimmunology 236 (1-2), 118-122, 2011 | 37 | 2011 |
Initial lymphocyte count and low BMI may affect fingolimod-induced lymphopenia C Warnke, T Dehmel, R Ramanujam, C Holmen, N Nordin, K Wolfram, ... Neurology 83 (23), 2153-2157, 2014 | 34 | 2014 |
Programmed death-1: from gene to protein in autoimmune human myasthenia gravis P Sakthivel, R Ramanujam, XB Wang, R Pirskanen, AK Lefvert Journal of neuroimmunology 193 (1-2), 149-155, 2008 | 34 | 2008 |
Factors associated with and long-term outcome of benign multiple sclerosis: a nationwide cohort study L Crielaard, A Kavaliunas, R Ramanujam, T Olsson, J Hillert, P Stridh, ... Journal of Neurology, Neurosurgery & Psychiatry 90 (7), 761-767, 2019 | 30 | 2019 |
A topological data analysis based classification method for multiple measurements H Riihimäki, W Chachólski, J Theorell, J Hillert, R Ramanujam BMC bioinformatics 21, 1-18, 2020 | 27 | 2020 |
Identity-by-descent mapping in a Scandinavian multiple sclerosis cohort H Westerlind, K Imrell, R Ramanujam, KM Myhr, EG Celius, HF Harbo, ... European Journal of Human Genetics 23 (5), 688-692, 2015 | 26 | 2015 |
Prevalence of anti-drug antibodies against interferon beta has decreased since routine analysis of neutralizing antibodies became clinical practice R Jungedal, M Lundkvist, E Engdahl, R Ramanujam, H Westerlind, ... Multiple Sclerosis Journal 18 (12), 1775-1781, 2012 | 22 | 2012 |
Accurate classification of secondary progression in multiple sclerosis using a decision tree R Ramanujam, F Zhu, K Fink, VD Karrenbauer, J Lorscheider, P Benkert, ... Multiple Sclerosis Journal 27 (8), 1240-1249, 2021 | 21 | 2021 |